Beauty shoppers searched almost as much in two days as in four, bought with intent at close to full price, and started their ...
- ASC36o, a once-weekly oral amylin receptor peptide agonist, is the most advanced drug candidate of Ascletis' once-weekly oral peptide pipeline and its Phase I study has started in the U.S.
The most positive outlook comes from operators of midsize and large-cabin aircraft, where demand for longer-range travel and ...
As one of the world's largest trade platforms, the Canton Fair has become an important channel connecting green technology ...
Colossal secured one of the world's few surviving moa eggs and will entrust it to New Zealand-based moa de-extinction program ...
Investors with losses on Baidu, Inc. securities can contact the Law Offices of Howard G. Smith about the Baidu, Inc. lawsuit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results